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Introduction: Approximately 9.4% of the US population has 
diabetes, while about 85% of the US population consumes over a 
100mg of caffeine daily. Whereas several epidemiological studies 
indicate that long-term coffee consumption reduces the risk of 
Type 2 diabetes mellitus (T2DM), the short-term effect of its 
consumption on glycemic control and diabetic complications 
warrants further elucidation. This is the focus of our research 
inquiry.
Methods: The blood glucose levels of 21 healthy individuals 
were measured using a glucometer after a carbohydrate-rich 
meal. For the control trial, each individual’s blood glucose levels 
was taken before the meal and then 15 mins, 45 mins, and 60 
mins after eating the meal. For the experimental trial, each 
individual repeated the control trial but 30 mins after consuming 
caffeine. The meal was composed of a bagel, cream cheese, and a 
glucose drink. 
Results: There was a significant time-dependent change in blood 
glucose levels during the control trial, F(2.980, 59.602) = 
21.492, p< 0.0005. There was a statistically significant increase 
in blood glucose levels with the caffeine trial - F(1, 20) = 
5.830, p = 0.025. 
Conclusion: Caffeine consumption with or about meal time 
acutely impairs glucose tolerance by increasing the rate of spike 
of blood glucose levels, decreased insulin sensitivity and 
potentially increases the risk of β-cell dysfunction. In a diabetic 
patient, this effect could make a tight blood glucose control 
difficult to achieve therefore requiring higher doses of 
hypoglycemic drugs and increasing the risk of diabetic 
complications like diabetic retinopathy, neuropathy or ischemic 
heart disease. 
Abstract
The postprandial spike in blood glucose levels initiates a glucose-
dependent secretion of insulin by the pancreatic beta cells which 
promotes the rapid uptake of glucose by skeletal muscles and  adipose 
tissues consequently re-establishing euglycemia. These responses are 
impaired in T2DM patients owing to a sustained elevation of counter-
regulatory hormones (like glucagon, epinephrine and cortisol) which 
causes persistent hyperglycemia. Impaired glucose tolerance is 
worsened by high glycemic index foods which cause a very rapid 
postprandial spike in blood glucose levels. Caffeine, the major 
component of coffee is a methylxanthine that has antagonistic 
properties against adenosine receptors (A1 and A2) and has been 
shown to cause elevations of plasma epinephrine levels. 
Consequently, caffeine has the acute effects of promoting lipolysis 
(increases release of free fatty acids into the bloodstream) and 
gluconeogenesis. This elevation of epinephrine promotes insulin 
resistance and in the context of the hyperglycemia and 
hyperinsulinemia in the immediate postprandial period, how will 
these counteracting biochemical activities affect the attainment of a 
good blood glucose control and the development or prevention of 
diabetic complications in a diabetic coffee drinker? This is the 
research question that we sought to investigate in this study.
Introduction
As opposed to the findings of several epidemiological studies on 
the long-term effects of coffee consumption on insulin sensitivity 
and risk of T2DM, our study suggests that;
1. Caffeine consumption with a carbohydrate-rich meal causes a 
more rapid spike in blood glucose.
2. Caffeine acutely impairs glucose tolerance necessitation the use 
of higher doses of oral hypoglycemic in T2DM patients.
3. Caffeine acutely increases insulin secretion but reduces insulin 
sensitivity. This potentially increases the risk of diabetic 
complications in T2DM patients.
Conclusion
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Results
The blood glucose of 21 healthy individuals were measured using 
a glucometer. For the control trial, each individual’s blood glucose 
levels was taken before the meal and then 15 mins, 45 mins, and 
60 mins after eating the meal. For the experimental trial, each 
individual repeated the control trial but only 30min after the 
consumption of caffeine. The meal was composed of a bagel, 
cream cheese, and a glucose drink. 
Methods
Figure 2. Caffeine significantly increased blood glucose levels over a 60 minute post
prandial period - F(1, 20) = 5.830, p = 0.025.
Figure 1. The blood glucose levels changed over time during the control trial, F(2.980,
59.602) = 21.492, p< 0.0005. The blood glucose levels increase significantly before they
gradually decline – the decline is due to the activity of insulin secreted in response to a
sudden spike in blood glucose level after food.
Figure 3. Blood glucose levels peaked at the 15 minute mark which coincides with the
peak activity and plasma concentration of caffeine (45 minutes from the time of caffeine
consumption). This peak point also indicates the peak of insulin secretion.
Also note that the blood glucose level at the start and end of the experiment is higher
for the caffeine trial than baseline
The following studies will help consolidate our understanding of 
the clinical implications of coffee consumption in a T2DM patient;
1. An evaluation of the incidence of complications in T2DM 
coffee drinkers.
2. The acute and long-term effects of the other ingredients found 
in coffee
3. The actual doses of oral hypoglycemic used to maintain 
glycemic control in T2DM coffee drinkers.
Future Studies
Figure 4. Caffeine consumption with a carbohydrate-rich meal produced a rate of
postprandial blood glucose spike that was twice that of the baseline trial. The implication
being that the strain on the pancreatic beta cells to secrete insulin will be much higher
with caffeine.
Prolonged pancreatic strain potentially induces beta cell apoptosis and insulin deficiency.
Figure 5. The rate of blood glucose decline from the peak values in the caffeine trial was
2 times higher than the baseline trials. This suggests that caffeine consumption with the
meal elicited a much higher level of insulin secretion than the baseline trials.
This wide fluctuation in blood glucose levels poses a huge challenge to maintaining
euglycemia.
